Chad A. Barnes

806 total citations
20 papers, 552 citations indexed

About

Chad A. Barnes is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Chad A. Barnes has authored 20 papers receiving a total of 552 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 8 papers in Pulmonary and Respiratory Medicine and 8 papers in Cancer Research. Recurrent topics in Chad A. Barnes's work include Pancreatic and Hepatic Oncology Research (11 papers), Renal cell carcinoma treatment (8 papers) and Cancer Genomics and Diagnostics (6 papers). Chad A. Barnes is often cited by papers focused on Pancreatic and Hepatic Oncology Research (11 papers), Renal cell carcinoma treatment (8 papers) and Cancer Genomics and Diagnostics (6 papers). Chad A. Barnes collaborates with scholars based in United States, Ireland and Germany. Chad A. Barnes's co-authors include Edwin N. Beckman, Kathleen K. Christians, Douglas B. Evans, Susan Tsai, Mohammed Aldakkak, Bradley A. Erickson, Paul S. Ritch, William A. Hall, Ben George and Kulwinder S. Dua and has published in prestigious journals such as Gastroenterology, Annals of Surgery and The Journal of Urology.

In The Last Decade

Chad A. Barnes

20 papers receiving 534 citations

Peers

Chad A. Barnes
Chad A. Barnes
Citations per year, relative to Chad A. Barnes Chad A. Barnes (= 1×) peers Э. Э. Топузов

Countries citing papers authored by Chad A. Barnes

Since Specialization
Citations

This map shows the geographic impact of Chad A. Barnes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chad A. Barnes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chad A. Barnes more than expected).

Fields of papers citing papers by Chad A. Barnes

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chad A. Barnes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chad A. Barnes. The network helps show where Chad A. Barnes may publish in the future.

Co-authorship network of co-authors of Chad A. Barnes

This figure shows the co-authorship network connecting the top 25 collaborators of Chad A. Barnes. A scholar is included among the top collaborators of Chad A. Barnes based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chad A. Barnes. Chad A. Barnes is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Barnes, Chad A. & Susan Tsai. (2022). Novel Considerations in Surgical Management of Individuals with Pancreatic Adenocarcinoma. Hematology/Oncology Clinics of North America. 36(5). 979–994. 1 indexed citations
2.
Barnes, Chad A., Mohammed Aldakkak, Kathleen K. Christians, et al.. (2020). Radiographic patterns of first disease recurrence after neoadjuvant therapy and surgery for patients with resectable and borderline resectable pancreatic cancer. Surgery. 168(3). 440–447. 15 indexed citations
3.
Barnes, Chad A., Mohammed Aldakkak, Callisia N. Clarke, et al.. (2020). Value of Pretreatment 18F-fluorodeoxyglucose Positron Emission Tomography in Patients With Localized Pancreatic Cancer Treated With Neoadjuvant Therapy. Frontiers in Oncology. 10. 500–500. 10 indexed citations
4.
Hall, William A., Kathleen K. Christians, Chad A. Barnes, et al.. (2020). Impact of Neoadjuvant Chemoradiation on Pathologic Response in Patients With Localized Pancreatic Cancer. Frontiers in Oncology. 10. 460–460. 19 indexed citations
5.
Barnes, Chad A., Mariana Chávez, Susan Tsai, et al.. (2019). Survival of patients with borderline resectable pancreatic cancer who received neoadjuvant therapy and surgery. Surgery. 166(3). 277–285. 46 indexed citations
6.
Chatzizacharias, N., Susan Tsai, Michael O. Griffin, et al.. (2018). Locally advanced pancreas cancer: Staging and goals of therapy. Surgery. 163(5). 1053–1062. 27 indexed citations
7.
Tsai, Susan, Ben George, Paul S. Ritch, et al.. (2018). Importance of Normalization of CA19-9 Levels Following Neoadjuvant Therapy in Patients With Localized Pancreatic Cancer. Annals of Surgery. 271(4). 740–747. 133 indexed citations
8.
Barnes, Chad A., Ashley N. Krepline, Mohammed Aldakkak, et al.. (2017). Is Adjuvant Therapy Necessary for All Patients with Localized Pancreatic Cancer Who Have Received Neoadjuvant Therapy?. Journal of Gastrointestinal Surgery. 21(11). 1793–1803. 23 indexed citations
9.
Barnes, Chad A., Elizabeth A. Krzywda, Kathleen K. Christians, et al.. (2017). Development of a high risk pancreatic screening clinic using 3.0 T MRI. Familial Cancer. 17(1). 101–111. 21 indexed citations
10.
Kadlec, Andrew O., Chad A. Barnes, Matthew J. Durand, & David D. Gutterman. (2017). Microvascular Adaptations to Exercise: Protective Effect of PGC-1 Alpha. American Journal of Hypertension. 31(2). 240–246. 8 indexed citations
11.
Kharofa, Jordan, Chad A. Barnes, Alexander C. Mackinnon, et al.. (2016). Correlation of SMAD4 Expression in Pretreatment Cytologic Specimens and Postneoadjuvant Treatment Surgical Specimens in Patients With Pancreatic Cancer. International Journal of Radiation Oncology*Biology*Physics. 96(2). S141–S141. 1 indexed citations
12.
Barnes, Chad A., Mohammed Aldakkak, Kathleen K. Christians, et al.. (2016). Su1401 Impact of Treatment Sequencing on Sites of First Recurrence in Patients with Localized Pancreatic Cancer. Gastroenterology. 150(4). S1213–S1213. 1 indexed citations
13.
Marcellin, Patrick, E.J. Heathcote, Marı́a Buti, et al.. (2011). 740 HBSAG KINETICS IN PATIENTS WITH CHRONIC HEPATITIS B (CHB) TREATED WITH TENOFOVIR DISOPROXIL FUMARATE (TDF) FOR UP TO 4 YEARS. Journal of Hepatology. 54. S297–S297. 14 indexed citations
14.
Barnes, Chad A., et al.. (2007). Comparison of adverse events of laser and light-assisted hair removal systems in skin types IV-VI.. PubMed. 6(1). 40–6. 25 indexed citations
15.
Raymond, Kimiyo, A. Bale, Chad A. Barnes, & Piero Rinaldo. (1999). Medium-chain acyl-CoA dehydrogenase deficiency: Sudden and unexpected death of a 45 year old woman. Genetics in Medicine. 1(6). 293–294. 36 indexed citations
16.
Kennedy, Susan, et al.. (1998). Semi-quantitation of urokinase plasminogen activator and its receptor in breast carcinomas by immunocytochemistry. British Journal of Cancer. 77(10). 1638–1641. 26 indexed citations
17.
Duggan, Catherine, Susan Kennedy, Chad A. Barnes, et al.. (1997). Plasminogen activator inhibitor type 2 in breast cancer. British Journal of Cancer. 76(5). 622–627. 60 indexed citations
18.
Fuselier, Harold A., et al.. (1983). Renal Cell Carcinoma: The Ochsner Medical Institution Experience (1945–1978). The Journal of Urology. 130(3). 445–448. 25 indexed citations
19.
Barnes, Chad A. & Edwin N. Beckman. (1983). Renal Oncocytoma and its Congeners. The Journal of Urology. 130(3). 619–619. 2 indexed citations
20.
Barnes, Chad A. & Edwin N. Beckman. (1983). Renal Oncocytoma and Its Congeners. American Journal of Clinical Pathology. 79(3). 312–318. 59 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026